n(1)-methylnicotinamide has been researched along with Gastric Ulcer in 1 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brzozowski, T | 1 |
| Konturek, PC | 1 |
| Chlopicki, S | 1 |
| Sliwowski, Z | 1 |
| Pawlik, M | 1 |
| Ptak-Belowska, A | 1 |
| Kwiecien, S | 1 |
| Drozdowicz, D | 1 |
| Pajdo, R | 1 |
| Slonimska, E | 1 |
| Konturek, SJ | 1 |
| Pawlik, WW | 1 |
1 other study available for n(1)-methylnicotinamide and Gastric Ulcer
| Article | Year |
|---|---|
Therapeutic potential of 1-methylnicotinamide against acute gastric lesions induced by stress: role of endogenous prostacyclin and sensory nerves.
Topics: Acute Disease; Animals; Epoprostenol; Gastric Acid; Gastric Mucosa; Male; Neurons, Afferent; Niacina | 2008 |